The adjusted mean total nasal symptom score AUC ( 0-6h ) was significantly reduced versus placebo with 200 mg of BI 671800 ( absolute difference , -0.85 ; percentage difference , -17 % ; P = .0026 ) , montelukast ( absolute difference , -0.74 ; percentage difference , -15 % ; P = .0115 ) , and fluticasone propionate ( absolute difference , -1.64 ; percentage difference , -33 % ; P < .0001 ) .